Evidence map›Paper›PMID 28595072›Full record

ArticleJournal of photochemistry and photobiology. B, Biology2017

Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro.

L F Freitas, M R Hamblin, F Anzengruber, J R Perussi, A O Ribeiro, V C A Martins, A M G Plepis

Open access · greenAbstract read
In one paragraph

Article in Journal of photochemistry and photobiology. B, Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Melanoma treatment: from conventional to nanotechnology.Journal of cancer research and clinical oncology · 2018
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

L F FreitasPrograma de Pós-Graduação Interunidades Bioengenharia - University of Sao Paulo, São Carlos, SP, Brazil. Electronic address: lucasfreitas@usp.br.
M R HamblinWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, United States.
F AnzengruberWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, United States.
J R PerussiPrograma de Pós-Graduação Interunidades Bioengenharia - University of Sao Paulo, São Carlos, SP, Brazil; Instituto de Química de São Carlos, University of Sao Paulo, São Carlos, SP, Brazil.
A O RibeiroUniversidade Federal do ABC, São Paulo, SP, Brazil.
V C A MartinsPrograma de Pós-Graduação Interunidades Bioengenharia - University of Sao Paulo, São Carlos, SP, Brazil; Instituto de Química de São Carlos, University of Sao Paulo, São Carlos, SP, Brazil.
A M G PlepisPrograma de Pós-Graduação Interunidades Bioengenharia - University of Sao Paulo, São Carlos, SP, Brazil; Instituto de Química de São Carlos, University of Sao Paulo, São Carlos, SP, Brazil.
Universidade de São Paulo · BRMassachusetts General Hospital · USUniversidade Federal do ABC · BR

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract InfectionsR21AI121700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2016 to 2017
$462k
NIAID NIH HHS R01 AI050875NIAID NIH HHS R21 AI121700
6 · The paper itself

Abstract

Studies indicate that hyperthermic therapy using gold nanorods and photodynamic activity with many photosensitizers can present a synergistic effect, and offer a great therapeutic potential, although more investigation needs to be performed before such approach could be implemented. We proposed to investigate the effect of the attachment of phthalocyanines on the surface of gold nanorods (well-characterized devices for hyperthermia generation) for the elimination of melanoma, one of the most important skin cancers due to its high lethality. Following the synthesis of nanorods through a seed-mediated method, the efficacy of photodynamic therapy (PDT) and hyperthermia was assessed separately. We chose to coat the nanorods with two tetracarboxylated zinc phthalocyanines - with or without methyl-glucamine groups. After the coating process, the phthalocyanines formed ionic complexes with the cetyltrimethylammonium bromide (CTAB) that was previously covering the nanoparticles. The nanorod-phthalocyanines complexes were analyzed by transmission electron microscopy (TEM), and their singlet oxygen and hydroxyl radical generation yields were assessed. Furthermore, they were tested in vitro with melanotic B16F10 and amelanotic B16G4F melanoma cells. The cells with nanoparticles were irradiated with laser (at 635nm), and the cell viability was assessed. The results indicate that the photodynamic properties of the phthalocyanines tested are enhanced when they are attached on the nanorods surface, and the combination of PDT and hyperthermia was able to eliminate over 90% of melanoma cells. This is a novel study because two tetracarboxylated phthalocyanines were used and because the same wavelength was irradiated to activate both the nanorods and the photosensitizers.

Indexed as

AnimalsCell Line, TumorCell ProliferationCell SurvivalGoldHumansHydroxyl RadicalIndolesIsoindolesLasersMelanoma, ExperimentalMiceMicroscopy, Electron, TransmissionNanotubesOrganometallic CompoundsPhotochemotherapyGoldHydroxyl RadicalIndolesIsoindolesOrganometallic CompoundsPhotosensitizing AgentsSinglet OxygenZinc CompoundsZn(II)-phthalocyanineCancerGoldHyperthermiaNanorodsPDTPhthalocyaninesPorphyrin

Identifiers

PMID28595072
PMCPMC5548294
OpenAlexW2617441886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.